Literature DB >> 23971905

Selection and characterization of single stranded DNA aptamers for the hormone abscisic Acid.

Alessia Grozio1, Victor M Gonzalez, Enrico Millo, Laura Sturla, Tiziana Vigliarolo, Luca Bagnasco, Lucrezia Guida, Cristina D'Arrigo, Antonio De Flora, Annalisa Salis, Elena M Martin, Marta Bellotti, Elena Zocchi.   

Abstract

The hormone abscisic acid (ABA) is a small molecule involved in pivotal physiological functions in higher plants. Recently, ABA has been also identified as an endogenous hormone in mammals, regulating different cell functions including inflammatory processes, stem cell expansion, insulin release, and glucose uptake. Aptamers are short, single-stranded (ss) oligonucleotidesable to recognize target molecules with high affinity. The small size of the ABA molecule represented a challenge for aptamer development and the aim of this study was to develop specific anti-ABA DNA aptamers. Biotinylated abscisic acid (bio-ABA) was immobilized on streptavidin-coated magnetic beads. DNA aptamers against bio-ABA were selected with 7 iterative rounds of the systematic evolution of ligands by exponential enrichment method (SELEX), each round comprising incubation of the ABA-binding beads with the ssDNA sequences, DNA elution, electrophoresis, and polymerase chain reaction (PCR) amplification. The PCR product was cloned and sequenced. The binding affinity of several clones was determined using bio-ABA immobilized on streptavidin-coated plates. Aptamer 2 and aptamer 9 showed the highest binding affinity, with dissociation constants values of 0.98 ± 0.14 μM and 0.80 ± 0.07 μM, respectively. Aptamers 2 and 9 were also able to bind free, unmodified ABA and to discriminate between different ABA enantiomers and isomers. Our findings indicate that ssDNA aptamers can selectively bind ABA and could be used for the development of ABA quantitation assays.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23971905      PMCID: PMC3760064          DOI: 10.1089/nat.2013.0418

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  45 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

Review 2.  Methods developed for SELEX.

Authors:  Subash Chandra Bose Gopinath
Journal:  Anal Bioanal Chem       Date:  2006-10-28       Impact factor: 4.142

3.  An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids.

Authors:  Brian R Baker; Rebecca Y Lai; McCall S Wood; Elaine H Doctor; Alan J Heeger; Kevin W Plaxco
Journal:  J Am Chem Soc       Date:  2006-03-15       Impact factor: 15.419

4.  High affinity ligands from in vitro selection: complex targets.

Authors:  K N Morris; K B Jensen; C M Julin; M Weil; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 5.  Biotechnological implications from abscisic acid (ABA) roles in cold stress and leaf senescence as an important signal for improving plant sustainable survival under abiotic-stressed conditions.

Authors:  X Xue-Xuan; S Hong-Bo; M Yuan-Yuan; X Gang; S Jun-Na; G Dong-Gang; R Cheng-Jiang
Journal:  Crit Rev Biotechnol       Date:  2010-09       Impact factor: 8.429

6.  Isolation of virus-neutralizing RNAs from a large pool of random sequences.

Authors:  W Pan; R C Craven; Q Qiu; C B Wilson; J W Wills; S Golovine; J F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Unprecedented dual binding behaviour of acridine group of dye: a combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents.

Authors:  Arivazhagan Rajendran; Balachandran Unni Nair
Journal:  Biochim Biophys Acta       Date:  2006-08-22

8.  DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers.

Authors:  Yi-Tak Lai; Jeffrey J DeStefano
Journal:  Nucleic Acid Ther       Date:  2012-05-03       Impact factor: 5.486

9.  Monoclonal antibody recognition of abscisic Acid analogs.

Authors:  M K Walker-Simmons; M J Reaney; S A Quarrie; P Perata; P Vernieri; S R Abrams
Journal:  Plant Physiol       Date:  1991-01       Impact factor: 8.340

10.  Abscisic acid activates the murine microglial cell line N9 through the second messenger cyclic ADP-ribose.

Authors:  Nicoletta Bodrato; Luisa Franco; Chiara Fresia; Lucrezia Guida; Cesare Usai; Annalisa Salis; Iliana Moreschi; Chiara Ferraris; Claudia Verderio; Giovanna Basile; Santina Bruzzone; Sonia Scarfì; Antonio De Flora; Elena Zocchi
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

View more
  5 in total

1.  Abscisic acid transport in human erythrocytes.

Authors:  Tiziana Vigliarolo; Lucrezia Guida; Enrico Millo; Chiara Fresia; Emilia Turco; Antonio De Flora; Elena Zocchi
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 2.  Microfluidic methods for aptamer selection and characterization.

Authors:  Sean K Dembowski; Michael T Bowser
Journal:  Analyst       Date:  2017-12-18       Impact factor: 4.616

Review 3.  Abscisic Acid as Pathogen Effector and Immune Regulator.

Authors:  Laurens Lievens; Jacob Pollier; Alain Goossens; Rudi Beyaert; Jens Staal
Journal:  Front Plant Sci       Date:  2017-04-19       Impact factor: 5.753

4.  Localized surface plasmon resonance-based abscisic acid biosensor using aptamer-functionalized gold nanoparticles.

Authors:  Shun Wang; Wei Li; Keke Chang; Juan Liu; Qingqian Guo; Haifeng Sun; Min Jiang; Hao Zhang; Jing Chen; Jiandong Hu
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 5.  Selection and Biosensor Application of Aptamers for Small Molecules.

Authors:  Franziska Pfeiffer; Günter Mayer
Journal:  Front Chem       Date:  2016-06-15       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.